Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme

<table>Kaplan Meier overall survival for all 31 patients for hypofractionated (blue line) and conventionally fractionated (red line) treatment.</table>

Neurology Research International

fig1

Figure 1

Figure 1: Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme 